Smith, Salley & Associates Iqvia Holdings Inc. Transaction History

Smith, Salley & Associates

$1.48 Billion
Q3 2024

A detailed history of Smith, Salley & Associates transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 10,393 shares of IQV stock, worth $2.05 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

10,393

Previous 10,016 3.76%

Holding current value

$2.05 Million

Previous $2.12 Million 16.25%

% of portfolio

0.17%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$206.81 - $251.55 $77,967 - $94,834	377 Added 3.76%	10,393 $2.46 Million
Q2 2024 Jul 29, 2024	BUY	$211.18 - $248.87 $226,173 - $266,539	1,071 Added 11.97%	10,016 $2.12 Million
Q1 2024 May 02, 2024	BUY	$208.23 - $259.1 $441,031 - $548,773	2,118 Added 31.02%	8,945 $2.26 Million
Q4 2023 Jan 24, 2024	BUY	$177.16 - $232.73 $60,234 - $79,128	340 Added 5.24%	6,827 $1.58 Million
Q3 2023 Oct 27, 2023	BUY	$196.75 - $231.96 $83,028 - $97,887	422 Added 6.96%	6,487 $1.28 Million
Q2 2023 Aug 04, 2023	BUY	$183.66 - $224.77 $12,672 - $15,509	69 Added 1.15%	6,065 $1.36 Million
Q1 2023 May 03, 2023	SELL	$188.0 - $240.65 $13,724 - $17,567	-73 Reduced 1.2%	5,996 $1.19 Million
Q4 2022 Feb 03, 2023	SELL	$172.45 - $226.53 $3,621 - $4,757	-21 Reduced 0.34%	6,069 $1.24 Million
Q3 2022 Nov 01, 2022	BUY	$181.14 - $248.26 $79,158 - $108,489	437 Added 7.73%	6,090 $1.1 Million
Q2 2022 Aug 01, 2022	SELL	$196.45 - $252.29 $15,323 - $19,678	-78 Reduced 1.36%	5,653 $1.23 Million
Q1 2022 May 10, 2022	SELL	$210.56 - $273.58 $161,710 - $210,109	-768 Reduced 11.82%	5,731 $1.33 Million
Q4 2021 Feb 10, 2022	BUY	$238.37 - $282.61 $203,329 - $241,066	853 Added 15.11%	6,499 $1.83 Million
Q3 2021 Nov 05, 2021	BUY	$239.54 - $265.23 $207,920 - $230,219	868 Added 18.17%	5,646 $1.35 Million
Q2 2021 Aug 09, 2021	BUY	$198.06 - $246.77 $94,276 - $117,462	476 Added 11.06%	4,778 $1.16 Million
Q1 2021 Apr 30, 2021	BUY	$173.0 - $194.59 $3,114 - $3,502	18 Added 0.42%	4,302 $831,000
Q4 2020 Jan 28, 2021	BUY	$153.99 - $180.39 $159,533 - $186,884	1,036 Added 31.9%	4,284 $768,000
Q3 2020 Nov 05, 2020	BUY	$141.28 - $169.75 $10,737 - $12,901	76 Added 2.4%	3,248 $512,000
Q2 2020 Aug 04, 2020	BUY	$100.04 - $153.06 $49,319 - $75,458	493 Added 18.4%	3,172 $450,000
Q1 2020 Apr 24, 2020	BUY	$84.0 - $166.11 $32,676 - $64,616	389 Added 16.99%	2,679 $289,000
Q4 2019 Jan 27, 2020	BUY	$137.59 - $155.95 $18,024 - $20,429	131 Added 6.07%	2,290 $354,000
Q3 2019 Oct 30, 2019	BUY	$148.25 - $161.46 $33,208 - $36,167	224 Added 11.58%	2,159 $323,000
Q2 2019 Jul 12, 2019	BUY	$132.28 - $160.9 $18,122 - $22,043	137 Added 7.62%	1,935 $311,000
Q1 2019 May 03, 2019	BUY	$109.96 - $144.45 $197,708 - $259,721	1,798 New	1,798 $259,000

Others Institutions Holding IQV

# of Institutions

1,143

Shares Held

142M

Call Options Held

828K

Put Options Held

951K

View Full List

About IQVIA HOLDINGS INC.

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $36.6B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

More about IQV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account

Smith, Salley & Associates Iqvia Holdings Inc. Transaction History